Patent No: 12,036,371 titled “Method of Accessing the Left Atrium with a Multi-Directional Steerable Catheter,”
News | EP Lab
BioCardia Announces United States Patent Issuance on Morph DNA Multi-Directional Steerable Catheter Transseptal Application

July 17, 2024 — BioCardia, Inc., a company focused on cellular and cell-derived therapeutics for the treatment of ...

Home July 17, 2024
Home
Optum webinar pic_1
Webinar
ON-DEMAND Webinar: Maximizing Structural Heart Workflows

On July 16, Diagnostic and Interventional Cardiology presented a webinar on "Maximizing Structural Heart Workflows ...

Home July 16, 2024
Home
Cardiovascular Consultants, Ltd. in Phoenix brings state-of-the-art cardiac imaging to its statewide network of Arizona practices
News | Computed Tomography (CT)
Phoenix Cardiology Practice Installs the First and Fastest Cardiovascular CT Scanner in the State, Arineta’s SpotLight Duo

July 16, 2024 — Arineta, a leader in advancing cardiovascular imaging solutions through cutting-edge technology, proudly ...

Home July 16, 2024
Home
Ultrahuman’s App Store ‘PowerPlugs’ launches with the Atrial Fibrillation (AFib) PowerPlug. The Ultrahuman Ring AIR is the first smart ring in the world to detect AFib
News | Wearables
Ultrahuman Announces its App Store ‘PowerPlugs’ with the World’s First AFib Detection Technology on a Smart Ring

July 16, 2024 — Ultrahuman, a pioneer in wearable technology, launches PowerPlugs, a platform for individual apps and ...

Home July 16, 2024
Home
A strategic deal to deliver virtual value-based cardiology care to health systems has been announced by the executive team at Guidehealth, a provider of AI-enabled healthcare services and Story Health, a digital company involved in specialty care delivery.
News | Cardiovascular Business
Strategic Deal to Deliver Virtual Value-based Cardiology Care Announced by Guidehealth and Story Health

July 15, 2024 — Guidehealth, an artificial intelligence (AI)-enabled healthcare services company, has announced a ...

Home July 15, 2024
Home
Data show that applying AI to VCG data provides more consistent and reliable detection of atrial flutter
News | Wearables
HeartBeam’s Artificial Intelligence Algorithm Combined with Vectorcardiography (VCG) Outperforms Expert Cardiologists in Detecting Arrhythmias

July 15, 2024 — HeartBeam, Inc., a medical technology company focused on transforming cardiac care through the power of ...

Home July 15, 2024
Home
Edwards Lifesciences announced it has exercised its option to acquire Innovalve Bio Medical Ltd.
News | Cardiovascular Business
Edwards Lifesciences to Acquire Innovalve

July 15, 2024 — Edwards Lifesciences announced it has exercised its option to acquire Innovalve Bio Medical Ltd., an ...

Home July 15, 2024
Home
Dr Pankaj Garg
News | Cardiac Imaging
Artificial Intelligence Speeds Up Heart Scans, Leading to Efficiency and Improving Outcomes

July 12, 2024 — Researchers have developed a groundbreaking method for analyzing heart MRI scans with the help of ...

Home July 12, 2024
Home
First implant of Amvia Sky in Canada performed at the Centre Hospitalier de l'Université de Montréal
News | Implantable Cardiac Monitor (ICM)
Amvia Sky Launched in Canada, the World’s First Pacemaker Approved for LBBAP

July 11, 2024 — Dr. Fadi Mansour performed the first Canadian implant of BIOTRONIK’s newest pacemaker and CRT-P ...

Home July 11, 2024
Home
Further expands HeartSciences extensive patent portfolio
News | Artificial Intelligence
HeartSciences Announces Allowance of U.S Patent for AI-ECG Assessment of Left Ventricular and Right Ventricular Heart Dysfunction

July 11, 2024 — Heart Test Laboratories, Inc. an artificial intelligence (AI)-powered medical technology company focused ...

Home July 11, 2024
Home
Medical device company R3 Vascular Inc., a developer of novel, best-in-class bioresorbable scaffolds for treating peripheral arterial disease (PAD), has announced the appointment of Josh Smale as its Vice President of Global Clinical and Scientific Affairs.
News | Cardiovascular Business
R3 Vascular Appoints Josh Smale as Vice President of Global Clinical and Scientific Affairs

July 11, 2024 — Medical device company R3 Vascular Inc., developer of novel, best-in-class bioresorbable scaffolds for ...

Home July 11, 2024
Home
Findings from an observational analysis of ARISE-HF trial participants, newly-published in the Journal of the American College of Cardiology, JACC, shed light on the racial and ethnic disparities in diabetic cardiomyopathy (DbCM).
News | ACC
Study Calls for Targeted Strategies for Managing Diabetic Cardiomyopathy Across Racial, Ethnic Groups

July 10, 2024 — Findings from an observational analysis of ARISE-HF trial participants, newly-published in the Journal ...

Home July 10, 2024
Home
the cardiology clinic of the future
Feature | Remote Monitoring | By Stuart Long
Step Into the Cardiology Clinic of the Future: Bringing Virtual Cardiac Care Delivery and Virtual Telemetry to Life in Your Practice’s Clinical Workflows

In a room of 20 people, it’s likely that about 10 of them, or half, will presently have some form of cardiovascular ...

Home July 10, 2024
Home
ProtheraCytes
News | Cardiovascular Clinical Studies
CellProthera and BioCardia Collaborate on Successful Phase II Trial of ProtheraCytes for the Treatment of Acute Myocardial Infarction

July 10, 2024 — CellProthera, a private company specializing in cell-based therapies for repairing ischemic tissues, and ...

Home July 10, 2024
Home
Patent covers brilaroxazine use for treating pulmonary hypertension (PH), pulmonary arterial hypertension (PAH) in any patients including treating PH in patients with chronic obstructive pulmonary disease (COPD) or sickle cell disease (SCD)
News | Pharmaceuticals
Reviva Announces Grant of European Patent Covering Use of Brilaroxazine for the Treatment of Pulmonary Hypertension

July 10, 2024 — Reviva Pharmaceuticals Holdings, Inc., a late-stage pharmaceutical company developing therapies that ...

Home July 10, 2024
Home
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now